BOULDER, CO--(Marketwired - June 11, 2014) - ViroCyt, LLC, the leader in rapid virus quantification, announced today that Michael Olszowy, PhD, has joined the team as Chief Technology Officer.
Dr. Olszowy is a formally trained cellular and molecular immunologist with 16 years of experience developing and commercializing life science technologies. Most recently, he held a number of increasingly senior positions at Thermo Fisher Scientific (formerly Life Technologies and Molecular Probes), where he played a pivotal role in the launch of the Attune® acoustic focusing cytometer. Previously, Michael served in a research management role at Caltag Laboratories and Senior Scientist at Pfizer. He earned his doctorate degree in Experimental Pathology with an Immunology focus at the University of Pittsburgh's School of Medicine, and conducted his postdoctoral research at the Washington University School of Medicine.
"My interest in ViroCyt stemmed from their courage in addressing the challenging area of small particle enumeration," stated Dr. Olszowy. "Their success thus far makes it clear that they have established a path of innovative growth in this area. I look forward to advancing the platform through further development of the instrument in combination with a strong reagent stream."
Added Robert Kline, ViroCyt President and CEO, "Dr. Olszowy brings to ViroCyt an outstanding record of development of innovative products in the bioscience field. He is a welcomed addition to our Management Team where he will be leading our ongoing efforts to continue to evolve the ground-breaking Virus Counter technology."
ViroCyt, LLC was created with the goal of bringing game-changing solutions to the Life Science industry. Our primary focus is replacing outdated technologies that slow down the pace of virus-related research and product development. Additional information can be found at http://www.virocyt.com.